Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
47.9 /100
Rank 10 out of 27 Sectors -
Advance/Decline
121/97
-
No. of Companies218
-
Avg. Market Cap10,373
-
Price to Earning Ratio31.22
-
Price to Earning Growth Ratio2.24
-
Price to Book Ratio8.06
-
Return on Equity18.12
-
Return on Capital Employed-
-
Return on Assets10.24
-
Dividend yield 1 year %0.24 %
-
Net Profit Growth Annual YoY %14.24 %
-
Net Profit Growth Qtr YoY %-23.17 %
-
Net Profit Growth Qtr QoQ %21.63 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
41,600.9
|
146.7
|
L
 -0.5%
H
144.6
147.1
|
L
 0.3%
H
142.5
148.7
|
L
 5.9%
H
135.5
149.5
|
L
 28.7%
H
113.4
149.5
|
L
 5.1%
H
96.4
153.8
|
L
 6.3%
H
96.4
160.3
|
L
 30.4%
H
96.4
179.6
|
L
 284.7%
H
34.2
179.6
|
| Amerisource Bergen Corp |
|
-
|
360.7
|
L
 0.1%
H
358.3
364.4
|
L
 6.8%
H
335.2
364.4
|
L
 16.8%
H
305.6
364.4
|
L
 29.6%
H
278.2
364.4
|
L
 24.3%
H
273.4
364.4
|
L
 122.6%
H
147.1
364.4
|
L
 247.0%
H
94.9
364.4
|
L
 269.5%
H
68.4
364.4
|
| Abbott |
|
219,723.9
|
126.4
|
L
 1.1%
H
124.7
126.6
|
L
 2.2%
H
122.4
126.7
|
L
 -5.0%
H
122.4
135.1
|
L
 -4.3%
H
122.4
137.5
|
L
 9.6%
H
110.9
141.2
|
L
 27.0%
H
89.7
141.2
|
L
 10.4%
H
89.7
142.6
|
L
 176.9%
H
36
142.6
|
| Alcon Inc Registered Shares |
|
36,570.8
|
74.0
|
L
 -0.4%
H
72.1
74
|
L
 0.1%
H
72.1
75.3
|
L
 -1.9%
H
71.6
77.0
|
L
 -13.4%
H
71.6
90.4
|
L
 -20.2%
H
71.6
99.2
|
L
 28.4%
H
57.5
101.1
|
L
 17.5%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
2,125.7
|
44.9
|
L
 -5.5%
H
44.7
47.4
|
L
 -1.1%
H
44.2
47.7
|
L
 10.8%
H
39.3
47.7
|
L
 37.2%
H
38.1
47.7
|
L
 54.8%
H
22.0
47.7
|
L
 295.7%
H
10.7
47.7
|
L
 160.3%
H
9.6
47.7
|
L
 308.3%
H
8.9
47.7
|
| Avanos Medical Inc |
|
521.3
|
11.2
|
L
 0.5%
H
11.1
11.5
|
L
 1.1%
H
10.6
12.7
|
L
 -0.6%
H
10.6
12.7
|
L
 4.6%
H
10.3
13
|
L
 -45.0%
H
9.3
21.1
|
L
 -53.3%
H
9.3
32.0
|
L
 -71.8%
H
9.3
53.6
|
L
 -64.6%
H
9.3
73.0
|
| Baxter International |
|
9,253.0
|
18
|
L
 0.1%
H
17.8
18.1
|
L
 -2.5%
H
17.5
18.4
|
L
 -21.4%
H
17.5
23.6
|
L
 -23.5%
H
17.5
24.9
|
L
 -50.1%
H
17.5
37.7
|
L
 -65.6%
H
17.5
56.9
|
L
 -77.2%
H
17.5
89.7
|
L
 -52.6%
H
17.5
95.2
|
| Becton, Dickinson & Company |
|
50,973.8
|
177.8
|
L
 0.3%
H
174.7
179.1
|
L
 -0.5%
H
162.3
180.2
|
L
 -7.6%
H
162.3
194.7
|
L
 -5.2%
H
162.3
200.2
|
L
 -21.7%
H
162.3
251.9
|
L
 -19.5%
H
162.3
287.3
|
L
 -23.0%
H
162.3
287.3
|
L
 19.5%
H
126.3
287.3
|
| Butterfly Network Inc |
|
563.3
|
2.2
|
L
 -0.9%
H
2.1
2.3
|
L
 -17.1%
H
2.1
3.1
|
L
 -10.8%
H
2.0
3.1
|
L
 60.4%
H
1.3
3.1
|
L
 -9.0%
H
1.3
5.0
|
L
 -40.7%
H
0.7
5.0
|
L
 -77.3%
H
0.7
29.1
|
L
H
0.7
29.1
|
| BioRad Laboratories Inc |
|
8,242.4
|
305.6
|
L
 -0.3%
H
302.3
307.5
|
L
 -4.4%
H
301.9
319.9
|
L
 3.1%
H
292.6
343.1
|
L
 15.2%
H
262.1
343.1
|
L
 -18.1%
H
211.4
373.7
|
L
 -19.4%
H
211.4
509.6
|
L
 -52.5%
H
211.4
832.7
|
L
 117.8%
H
122.0
832.7
|
| Bausch Lomb Corp |
|
5,507.7
|
15.6
|
L
 0.1%
H
15.3
15.6
|
L
 4.1%
H
14.6
16
|
L
 6.1%
H
13.8
16
|
L
 12.7%
H
13.5
16
|
L
 -23.2%
H
10.5
20.7
|
L
 2.6%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
148,273.9
|
100.0
|
L
 1.0%
H
98.7
100.3
|
L
 -0.7%
H
97.5
100.8
|
L
 4.3%
H
94.5
105.5
|
L
 -2.9%
H
90.7
109.5
|
L
 15.1%
H
86.0
109.5
|
L
 138.4%
H
41.0
109.5
|
L
 180.2%
H
33.0
109.5
|
L
 432.6%
H
15.7
109.5
|
| Cardinal Health |
|
48,391.0
|
203.7
|
L
 2.9%
H
197.2
203.7
|
L
 6.8%
H
188.2
203.7
|
L
 30.0%
H
151.9
203.7
|
L
 32.8%
H
137.8
203.7
|
L
 72.3%
H
114.6
203.7
|
L
 151.5%
H
68.5
203.7
|
L
 286.9%
H
45.9
203.7
|
L
 130.1%
H
39.1
203.7
|
| Conmed Corp |
|
1,361.7
|
44.0
|
L
 -0.5%
H
43.6
46.0
|
L
 -0.1%
H
41.6
46.2
|
L
 -4.2%
H
41.6
49.6
|
L
 -17.6%
H
41.6
56.6
|
L
 -41.2%
H
41.6
78
|
L
 -41.7%
H
41.6
138.5
|
L
 -45.2%
H
41.6
159.1
|
L
 6.2%
H
35.5
159.1
|
| Cooper Companies |
|
13,936.5
|
70.1
|
L
 1.6%
H
68.1
70.2
|
L
 0.3%
H
67.2
70.2
|
L
 1.6%
H
67.2
76.2
|
L
 1.3%
H
61.8
76.2
|
L
 -32.2%
H
61.8
106.6
|
L
 3.6%
H
61.8
112.4
|
L
 -16.0%
H
61.1
115.9
|
L
 82.9%
H
29.8
115.9
|
| Danaher |
|
148,291.0
|
209.9
|
L
 -0.4%
H
207.8
211.3
|
L
 -2.5%
H
207.8
216.1
|
L
 0.6%
H
202.1
235.0
|
L
 5.8%
H
180.0
235.0
|
L
 -14.7%
H
171.0
258.2
|
L
 -15.7%
H
171.0
281.7
|
L
 -14.5%
H
171.0
334.0
|
L
 189.1%
H
61.6
334.0
|
| Edwards Lifesciences |
|
48,391.2
|
83.4
|
L
 1.2%
H
82.3
83.8
|
L
 1.1%
H
80.2
84.8
|
L
 8.7%
H
72.3
87.1
|
L
 7.0%
H
72.3
87.1
|
L
 26.7%
H
64.9
87.1
|
L
 21.3%
H
58.9
96.1
|
L
 6.9%
H
58.9
131.7
|
L
 218.3%
H
24.1
131.7
|
| Glaukos Corporation |
|
4,816.5
|
83.9
|
L
 2.5%
H
80.9
84.4
|
L
 -4.8%
H
80.9
88.7
|
L
 -0.3%
H
73.2
102.8
|
L
 -4.7%
H
73.2
102.8
|
L
 -39.8%
H
73.2
163.7
|
L
 78.2%
H
40.5
163.7
|
L
 39.0%
H
33.3
163.7
|
L
 329.2%
H
14.3
163.7
|
| Globus Medical Inc Ordinary |
|
11,227.8
|
83.9
|
L
 35.9%
H
79.5
85.0
|
L
 38.9%
H
59.5
85.0
|
L
 41.4%
H
56.5
85.0
|
L
 55.2%
H
54.2
85.0
|
L
 2.3%
H
51.8
94.9
|
L
 30.5%
H
43.4
94.9
|
L
 55.2%
H
43.4
94.9
|
L
 214.5%
H
19.3
94.9
|
| Haemonetics Corp |
|
3,199.9
|
68.4
|
L
 1.9%
H
67.3
71.4
|
L
 36.7%
H
49.2
71.4
|
L
 38.8%
H
48.2
71.4
|
L
 22.9%
H
47.3
71.4
|
L
 -21%
H
47.3
95.0
|
L
 -18.2%
H
47.3
98.0
|
L
 -30.5%
H
43.5
142.1
|
L
 101.1%
H
26.0
142.1
|
| Herbalife Nutrition |
|
939.1
|
9.1
|
L
 -1.2%
H
8.5
9.2
|
L
 13.6%
H
7.7
9.5
|
L
 2.6%
H
7.6
9.5
|
L
 5.5%
H
7.6
10.3
|
L
 8.6%
H
5.0
10.8
|
L
 -44.5%
H
5.0
21.3
|
L
 -81.3%
H
5.0
59
|
L
 -67.0%
H
5.0
61.8
|
| Inspire Medical Systems Inc |
|
2,376.5
|
81.8
|
L
 -2.4%
H
80.7
84.2
|
L
 13.5%
H
71.5
89.4
|
L
 6.5%
H
71.5
89.4
|
L
 6.2%
H
70.8
97.3
|
L
 -59.2%
H
70.8
216.0
|
L
 -60.5%
H
70.8
330
|
L
 -51.3%
H
70.8
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
2,391.7
|
68.3
|
L
 2.4%
H
66.3
68.4
|
L
 5.7%
H
63.8
70.2
|
L
 -34.2%
H
62
112.0
|
L
 -35.4%
H
62
112.0
|
L
 -49.3%
H
62
146.4
|
L
 5.7%
H
61.9
146.4
|
L
 19.8%
H
50.1
146.4
|
L
 31.8%
H
18.1
146.4
|
| McKesson |
|
105,646.8
|
852.0
|
L
 -0.8%
H
846.4
867.6
|
L
 5.0%
H
793.3
867.6
|
L
 13.6%
H
744
867.6
|
L
 28.5%
H
637
867.6
|
L
 40.2%
H
558.1
867.6
|
L
 115.3%
H
331.8
867.6
|
L
 398.5%
H
168.9
867.6
|
L
 363.7%
H
106.1
867.6
|
| Medtronic |
|
118,257.2
|
92.2
|
L
 2.4%
H
90.2
92.2
|
L
 1.7%
H
89.0
92.2
|
L
 -6.2%
H
89.0
98.7
|
L
 1.1%
H
87.5
99.4
|
L
 4.6%
H
79.3
99.4
|
L
 7.8%
H
68.9
99.4
|
L
 -11.0%
H
68.9
135.9
|
L
 21.2%
H
68.9
135.9
|
| Mettler-Toledo International |
|
29,649.2
|
1,439.4
|
L
 0.0%
H
1378.0
1442.5
|
L
 1.6%
H
1376.9
1449.8
|
L
 10.0%
H
1270.6
1454.7
|
L
 16.4%
H
1187.8
1454.7
|
L
 2.0%
H
946.7
1454.7
|
L
 10.8%
H
928.5
1616.0
|
L
 21.9%
H
928.5
1714.8
|
L
 339.3%
H
291.3
1714.8
|
| Envista Holdings Corp |
|
3,198.1
|
19.5
|
L
 -0.2%
H
19.4
19.8
|
L
 -4.4%
H
19.4
20.7
|
L
 -4.8%
H
18.8
21.2
|
L
 -3.2%
H
18.8
21.7
|
L
 -9.1%
H
14.2
22.7
|
L
 -44.8%
H
14.2
43.3
|
L
 -28.8%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens Minor Inc |
|
246.0
|
3.2
|
L
 1.9%
H
3.1
3.2
|
L
 -19.9%
H
3.1
3.9
|
L
 -33.2%
H
3.1
5.6
|
L
 -49.6%
H
3.1
7.1
|
L
 -75.1%
H
3.1
15.5
|
L
 -83.4%
H
3.1
28.4
|
L
 -87.0%
H
3.1
49.2
|
L
 -91.3%
H
2.4
49.2
|
| Penumbra Inc |
|
10,424.6
|
266.2
|
L
 0.6%
H
259.1
270
|
L
 17.1%
H
221.3
272
|
L
 6.9%
H
221.3
272
|
L
 10.6%
H
221.3
288.9
|
L
 14.2%
H
221.3
310
|
L
 49.4%
H
148
348.7
|
L
 6.0%
H
114.9
348.7
|
L
 617.9%
H
36.7
348.7
|
| Koninklijke Philips NV ADR |
|
26,789.1
|
28.2
|
L
 -0.3%
H
27.9
28.2
|
L
 3.1%
H
27.0
28.5
|
L
 1.2%
H
26.1
29.3
|
L
 5.9%
H
26.1
29.3
|
L
 2.3%
H
21.5
29.3
|
L
 116.4%
H
12.7
32.9
|
L
 -44.9%
H
11.8
61.2
|
L
 5.7%
H
11.8
61.2
|
| Qiagen NV |
|
9,445.6
|
43.6
|
L
 1.2%
H
42.8
43.6
|
L
 -7.0%
H
42.8
47.4
|
L
 -6.9%
H
42.8
49.6
|
L
 -9.9%
H
42.8
50.0
|
L
 -4.1%
H
37.6
51.9
|
L
 -2.0%
H
36.8
54.3
|
L
 -20.2%
H
36.8
62.6
|
L
 57.5%
H
22.0
62.6
|
| Vicarious Surgical Inc |
|
28.6
|
4.4
|
L
 0.7%
H
4.2
4.4
|
L
 -18.0%
H
4.2
5.5
|
L
 -33.1%
H
4.2
7.5
|
L
 -51.0%
H
4.2
10.5
|
L
 -45.2%
H
4.2
19
|
L
 -99.9%
H
4.2
3523.5
|
L
 -99.9%
H
4.2
14207.0
|
L
H
4.2
14207.0
|
| ResMed |
|
36,709.1
|
251.5
|
L
 0.7%
H
245.9
251.5
|
L
 1.9%
H
241.6
252.2
|
L
 -11.2%
H
239.4
284.9
|
L
 -10.2%
H
239.4
293.8
|
L
 1.2%
H
199.9
293.8
|
L
 18.3%
H
132.2
293.8
|
L
 17.4%
H
132.2
301.3
|
L
 330.9%
H
50.8
301.3
|
| STERIS (Ireland) |
|
25,888.2
|
263.8
|
L
 1.4%
H
258.5
264.7
|
L
 11.9%
H
233.3
265.6
|
L
 9.2%
H
232.2
265.6
|
L
 11.7%
H
232.2
265.6
|
L
 22.4%
H
201.0
265.6
|
L
 61.3%
H
160.2
265.6
|
L
 45.2%
H
159.2
265.6
|
L
 249.5%
H
61.4
265.6
|
| Stevanato Group Spa |
|
6,579.4
|
24.1
|
L
 -1.3%
H
23.7
24.6
|
L
 -4.4%
H
23.1
27
|
L
 0.2%
H
23.0
28.0
|
L
 -0.4%
H
21.5
28
|
L
 6.1%
H
17.5
28
|
L
 70.7%
H
13.7
36.3
|
L
H
13.4
36.3
|
L
H
13.4
36.3
|
| Stryker |
|
136,154.3
|
356.0
|
L
 0.6%
H
352.5
357.5
|
L
 -0.1%
H
349.2
364.9
|
L
 -3.6%
H
349.2
392.6
|
L
 -5.4%
H
349.2
396.9
|
L
 -3.7%
H
329.2
406.2
|
L
 66.7%
H
206.7
406.2
|
L
 66.8%
H
188.8
406.2
|
L
 264.8%
H
86.7
406.2
|
| Smith Nephew plc ADR |
|
14,086.3
|
33.2
|
L
 2.4%
H
32.8
33.6
|
L
 -9.8%
H
31.8
37.1
|
L
 -7%
H
31.8
37.5
|
L
 -7.9%
H
31.8
38.8
|
L
 34.5%
H
23.7
38.8
|
L
 37.3%
H
21.5
38.8
|
L
 -10.2%
H
21.5
46.1
|
L
 -1.5%
H
21.5
52.3
|
| Teleflex Incorporated |
|
4,834.9
|
109.4
|
L
 0.8%
H
108.0
111.0
|
L
 -12.1%
H
102.6
126
|
L
 -13.8%
H
102.6
136.0
|
L
 -5.3%
H
102.6
136.0
|
L
 -44.8%
H
102.6
200.2
|
L
 -46.4%
H
102.6
276.4
|
L
 -67.4%
H
102.6
449.4
|
L
 -17.7%
H
102.6
449.4
|
| Thermo Fisher |
|
215,059.1
|
572.4
|
L
 1.1%
H
563.3
577.4
|
L
 0.9%
H
554.2
577.4
|
L
 6.2%
H
519.5
578.2
|
L
 25.9%
H
451.4
578.2
|
L
 3.0%
H
385.5
611.0
|
L
 16.3%
H
385.5
627.9
|
L
 8.5%
H
385.5
672.3
|
L
 326.2%
H
119.8
672.3
|
| Waters |
|
22,128.5
|
371.7
|
L
 0.1%
H
364.9
372.8
|
L
 6.3%
H
341.1
382.0
|
L
 16.8%
H
319.6
382.0
|
L
 33.7%
H
275.1
382.0
|
L
 -3.7%
H
275.1
423.6
|
L
 21.3%
H
231.9
423.6
|
L
 67.1%
H
221.1
428.2
|
L
 180.6%
H
112
428.2
|
| West Pharma Services |
|
19,499.5
|
271.0
|
L
 -1.6%
H
268.2
280.8
|
L
 -3.9%
H
262.5
288.0
|
L
 1.9%
H
257.5
322.3
|
L
 12.7%
H
237.2
322.3
|
L
 -16.2%
H
187.4
348.9
|
L
 20.0%
H
187.4
415.7
|
L
 -8.4%
H
187.4
475.4
|
L
 325.9%
H
53.9
475.4
|
| Zimmer Biomet |
|
17,539.1
|
88.5
|
L
 0.0%
H
87.4
90.2
|
L
 -12.0%
H
85.3
103.7
|
L
 -10.7%
H
85.3
106.9
|
L
 -10.1%
H
85.3
108.3
|
L
 -18.6%
H
85.3
114.7
|
L
 -17.7%
H
85.3
149.3
|
L
 -32.1%
H
85.3
169.7
|
L
 -12.3%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
8,792.2
|
305.4
|
L
H
305.4
305.4
|
L
 0.7%
H
305.4
306.1
|
L
 7.2%
H
303.2
321.1
|
L
 23.6%
H
283.9
321.1
|
L
 -8.8%
H
225.3
359.2
|
L
 -8.1%
H
225.3
373.4
|
L
 -8.1%
H
225.3
373.4
|
L
 -8.1%
H
225.3
373.4
|
| Haleon plc ADR |
|
42,124.8
|
9.5
|
L
 0.5%
H
9.4
9.5
|
L
 2.1%
H
9.3
9.5
|
L
 7.3%
H
9.0
9.5
|
L
H
8.7
10.0
|
L
 -1.5%
H
8.7
11.4
|
L
 47.4%
H
6.2
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
| Revvity |
|
10,292.2
|
90.8
|
L
 1.4%
H
88.5
91.0
|
L
 -3%
H
88.5
94.3
|
L
 -0.5%
H
88.1
100.4
|
L
 5%
H
81.4
100.4
|
L
 -26.8%
H
81.4
128.3
|
L
 -29.7%
H
79.5
150.2
|
L
 -35.8%
H
79.5
203.2
|
L
 74.8%
H
39.5
203.2
|
| Aethlon Medical Inc |
|
3.2
|
4.2
|
L
 -1.6%
H
4.0
4.2
|
L
 -20.3%
H
4.0
5.2
|
L
 -42.5%
H
4.0
7.7
|
L
 -68.7%
H
4.0
27.4
|
L
 -87%
H
4.0
84.4
|
L
 -99.0%
H
4.0
695.6
|
L
 -99.6%
H
4.0
9992
|
L
 -100.0%
H
4.0
109078.8
|
| Ainos Inc |
|
12.7
|
2.7
|
L
 -8.6%
H
2.6
2.9
|
L
 -31.0%
H
2.6
4.4
|
L
 -25%
H
2.6
4.4
|
L
 -7.3%
H
2.3
4.5
|
L
 9.4%
H
2
5
|
L
 -92.5%
H
2
45.8
|
L
H
0.4
1781.3
|
L
 602.6%
H
0.1
1781.3
|
| Airsculpt Technologies Inc |
|
382.1
|
6.1
|
L
 -41.7%
H
5.7
8.1
|
L
 -41.2%
H
5.7
10.7
|
L
 -23.8%
H
5.7
12
|
L
 -1.3%
H
5.6
12
|
L
 -14.9%
H
1.5
12
|
L
 18.1%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
9,674.8
|
134.8
|
L
 0.8%
H
132.4
135.0
|
L
 -2.2%
H
131.9
138.7
|
L
 3.4%
H
124.9
150.8
|
L
 -2.8%
H
122
150.8
|
L
 -39.3%
H
122
246.2
|
L
 -25.7%
H
122
413.2
|
L
 -71.8%
H
122
737.5
|
L
 100.7%
H
57.3
737.5
|
| Angiodynamic Inc |
|
495.2
|
12.0
|
L
 2.5%
H
11.7
12.2
|
L
 -0.1%
H
11.5
12.2
|
L
 8.8%
H
10.9
12.6
|
L
 40.9%
H
8.4
12.8
|
L
 68.1%
H
6.6
13.5
|
L
 -17.1%
H
5.3
16.0
|
L
 5.5%
H
5.3
32
|
L
 -9.3%
H
5.3
32
|
| Anika Therapeutics Inc |
|
142.0
|
9.9
|
L
 1.0%
H
9.5
9.9
|
L
 1.0%
H
9.4
10.8
|
L
 8.4%
H
8.7
10.8
|
L
 19.8%
H
7.9
10.8
|
L
 -42.8%
H
7.9
18.4
|
L
 -66.6%
H
7.9
32.5
|
L
 -69.8%
H
7.9
48.4
|
L
 -76.9%
H
7.9
75.7
|
| Apyx Medical Corp |
|
146.4
|
3.9
|
L
 15.5%
H
3.2
4.0
|
L
 27.7%
H
2.9
4.0
|
L
 36.3%
H
2.6
4.0
|
L
 97.5%
H
1.7
4.0
|
L
 217.2%
H
0.8
4.0
|
L
 -22.6%
H
0.8
8.0
|
L
 -35.3%
H
0.8
17.5
|
L
 94.5%
H
0.8
17.5
|
| Accuray Inc |
|
132.6
|
1.2
|
L
 -4.1%
H
1.2
1.3
|
L
 -17.0%
H
1.1
1.5
|
L
 -25.5%
H
1.1
2.1
|
L
 -11.4%
H
1.1
2.1
|
L
 -44.0%
H
1.1
3.0
|
L
 -44.0%
H
1.1
4.3
|
L
 -59.5%
H
1.1
6.0
|
L
 -83.5%
H
1.1
7.5
|
| Alphatec Holdings Inc |
|
2,941.3
|
19.8
|
L
 1.5%
H
19.5
20.2
|
L
 4.3%
H
17.9
20.2
|
L
 47.2%
H
13.1
20.2
|
L
 32.9%
H
13.1
20.2
|
L
 110.4%
H
8.2
20.2
|
L
 101.6%
H
4.9
20.2
|
L
 94.9%
H
4.9
20.2
|
L
 415.6%
H
1.2
20.2
|
| Atricure Inc |
|
1,593.4
|
32.1
|
L
 1.8%
H
31.1
32.9
|
L
 -7.2%
H
31.1
35.1
|
L
 -6.1%
H
30.9
38.4
|
L
 -10.7%
H
30.9
38.4
|
L
 -14.2%
H
28.3
43.1
|
L
 -20.7%
H
18.9
59.6
|
L
 -12.7%
H
18.9
89.2
|
L
 53.9%
H
13.4
89.2
|
| Axogen Inc |
|
1,087.1
|
23.6
|
L
 -1.8%
H
23.2
24.2
|
L
 6.1%
H
21.9
24.3
|
L
 39.5%
H
15.3
24.3
|
L
 67.5%
H
13.6
24.3
|
L
 77.6%
H
9.2
24.3
|
L
 120.7%
H
3.5
24.3
|
L
 69.7%
H
3.5
24.3
|
L
 317.9%
H
3.5
56.9
|
| Bone Biologics Corp |
|
2.8
|
1.8
|
L
 -8.4%
H
1.7
1.9
|
L
 -17.8%
H
1.7
2.1
|
L
 -32.4%
H
1.7
2.8
|
L
 -31.1%
H
1.7
4.1
|
L
 -77.6%
H
1.7
10.1
|
L
 -99.7%
H
1.7
633.6
|
L
 -100.0%
H
1.7
21600
|
L
H
1.7
169920
|
| BioAffinity Technologies Inc |
|
9.3
|
2.1
|
L
 0.5%
H
1.9
2.1
|
L
 -15.9%
H
1.9
2.4
|
L
 -15.9%
H
1.9
3.7
|
L
 -75.5%
H
1.9
13.5
|
L
 -94.8%
H
1.9
46.5
|
L
 -97.4%
H
1.9
119.7
|
L
H
1.9
466.5
|
L
H
1.9
466.5
|
| Bluejay Diagnostics Inc |
|
2.6
|
1.6
|
L
 -1.3%
H
1.4
1.6
|
L
 -20.3%
H
1.4
2.0
|
L
 -26.6%
H
1.4
4.2
|
L
 6.8%
H
1.3
4.2
|
L
 1644.4%
H
0.1
10.2
|
L
 -98.8%
H
0.1
140.8
|
L
H
0.1
1000
|
L
H
0.1
1000
|
| Biolife Solutions Inc |
|
1,248.5
|
25.9
|
L
 -4.0%
H
25.5
27.2
|
L
 -7.0%
H
25.5
28.2
|
L
 -1.4%
H
25.5
29.6
|
L
 25.6%
H
21.2
29.6
|
L
 -0.8%
H
19.1
29.6
|
L
 35.2%
H
8.9
29.6
|
L
 -23.4%
H
8.9
60.7
|
L
 1022.5%
H
1.4
60.7
|
| Biomerica Inc |
|
7.3
|
2.5
|
L
 -3.5%
H
2.4
2.5
|
L
 -11.8%
H
2.4
2.8
|
L
 -13.4%
H
2.4
3.2
|
L
 -20.9%
H
2.4
4.6
|
L
 547.4%
H
0.3
4.9
|
L
 -23.8%
H
0.2
4.9
|
L
 -59%
H
0.2
8.2
|
L
 176.4%
H
0.2
23.4
|
| Bruker Corp |
|
6,067.0
|
39.9
|
L
 1.6%
H
38.4
40.1
|
L
 2.5%
H
37
40.7
|
L
 15.5%
H
34.1
41.1
|
L
 28.2%
H
28.5
41.1
|
L
 -34.0%
H
28.5
64.6
|
L
 -39.8%
H
28.5
94.9
|
L
 -14.1%
H
28.5
94.9
|
L
 90.4%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
10.9
|
1.4
|
L
 -2.1%
H
1.3
1.4
|
L
 -11.0%
H
1.3
1.6
|
L
 -15.4%
H
1.3
1.7
|
L
 -4.2%
H
1.2
1.9
|
L
 -12.2%
H
1.2
2.6
|
L
 -54.6%
H
1.0
7.1
|
L
 -97.9%
H
1.0
132.4
|
L
 -100.0%
H
0.4
20040
|
| Streamex Corp |
|
158.4
|
4.5
|
L
 -4.9%
H
4.2
4.6
|
L
 -7.8%
H
4.2
5.1
|
L
 -23.6%
H
4.2
6.5
|
L
 22.0%
H
3.7
7.4
|
L
 155.1%
H
0.4
14.1
|
L
 1260.6%
H
0.1
14.1
|
L
 37.3%
H
0.1
14.1
|
L
 28.3%
H
0.1
14.1
|
| Bioventus Inc Ordinary Shares |
|
499.0
|
7.5
|
L
 -0.4%
H
7.3
7.6
|
L
 13.7%
H
6.5
8.3
|
L
 12.0%
H
6.4
8.3
|
L
 7.5%
H
6.3
8.3
|
L
 -33.7%
H
5.8
12.6
|
L
 5.5%
H
0.8
14.4
|
L
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway ADR |
|
304.9
|
15.6
|
L
H
15.1
16.0
|
L
 -7.5%
H
15.1
17.9
|
L
 2.4%
H
14.6
17.9
|
L
 31.8%
H
11.7
17.9
|
L
 46.3%
H
7.8
17.9
|
L
 354.5%
H
1.4
17.9
|
L
 169.3%
H
1.4
17.9
|
L
H
1.4
17.9
|
| Cardio Diagnostics Holdings |
|
6.8
|
3.9
|
L
 3.8%
H
3.6
3.9
|
L
 -4.5%
H
3.6
4.1
|
L
 -11.7%
H
3.6
4.7
|
L
 -0.3%
H
3.3
4.9
|
L
 -69.7%
H
3.2
53.1
|
L
 -93.2%
H
3.2
255
|
L
H
3.2
307.5
|
L
H
3.2
307.5
|
| Caredx Inc |
|
803.4
|
15.6
|
L
 4.1%
H
14.7
16.0
|
L
 4.1%
H
14.3
16.6
|
L
 6.5%
H
14.0
16.6
|
L
 29.4%
H
11.3
16.6
|
L
 -34.6%
H
11.0
26.4
|
L
 -1.5%
H
4.8
34.8
|
L
 -71.1%
H
4.8
99.8
|
L
 247.1%
H
0.8
99.8
|
| Celcuity Inc |
|
3,161.6
|
74.5
|
L
 0.4%
H
72.1
74.9
|
L
 -3.4%
H
71.1
78.9
|
L
 51.4%
H
45.0
83
|
L
 68.4%
H
44.2
83
|
L
 373.7%
H
7.6
83
|
L
 638.6%
H
7.5
83
|
L
 1209.7%
H
4.8
83
|
L
H
4.0
83
|
| Creative Medical Technology |
|
7.8
|
3.0
|
L
 1.7%
H
2.9
3.3
|
L
 -4.7%
H
2.6
3.3
|
L
 -11.4%
H
2.6
6.3
|
L
 -19.0%
H
2.6
6.3
|
L
 -4.4%
H
1.7
6.9
|
L
 -39.0%
H
1.7
14.2
|
L
 -62.3%
H
1.7
650
|
L
 -100.0%
H
1.7
525000
|
| Cerus Corp |
|
328.5
|
1.7
|
L
 21.3%
H
1.4
1.7
|
L
 16.3%
H
1.4
1.7
|
L
 6.9%
H
1.4
1.7
|
L
 37.9%
H
1.2
1.7
|
L
 -2.8%
H
1.1
2.2
|
L
 -54.4%
H
1.1
4.3
|
L
 -69.0%
H
1.1
8.9
|
L
 -68.2%
H
1.1
8.9
|
| CheckCap |
|
9.7
|
1.7
|
L
 37.2%
H
1.2
1.7
|
L
 19.4%
H
1.2
1.7
|
L
 -22.1%
H
1.2
2.3
|
L
 167.7%
H
0.6
3.1
|
L
 53.7%
H
0.6
3.1
|
L
 -67.0%
H
0.6
5.9
|
L
 -69.3%
H
0.6
89.8
|
L
 -99.8%
H
0.6
173376
|
| CollPlant Biotechnologies |
|
25.3
|
2.0
|
L
 -8.7%
H
2.0
2.1
|
L
 -7.9%
H
2.0
2.3
|
L
 -9.6%
H
2.0
2.7
|
L
 -30.9%
H
1.9
3.2
|
L
 -47.5%
H
1.3
5.0
|
L
 -66.9%
H
1.3
14.0
|
L
 -72.6%
H
1.3
24.3
|
L
 -92.9%
H
1.3
24.3
|
| ClearPoint Neuro Inc |
|
449.4
|
15.8
|
L
 -13.3%
H
14.7
16.2
|
L
 -31.9%
H
14.7
19.7
|
L
 -40.1%
H
14.7
30.1
|
L
 44.8%
H
10.1
30.1
|
L
 16.0%
H
9.8
30.1
|
L
 60.3%
H
4.1
30.1
|
L
 137.7%
H
4.1
31.3
|
L
 -26.8%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
147.5
|
2.2
|
L
 -2.7%
H
2.1
2.3
|
L
 -6.8%
H
2.1
2.4
|
L
 -2.2%
H
2.1
2.5
|
L
 -9.1%
H
1.9
2.6
|
L
 -46.5%
H
1.9
5.6
|
L
 65.9%
H
0.9
6.4
|
L
 -87.9%
H
0.9
25.5
|
L
 -99.4%
H
0.7
517.0
|
| Castle Biosciences Inc |
|
964.4
|
33.0
|
L
 -1.5%
H
32.7
34.1
|
L
 29.6%
H
25.3
34.4
|
L
 44.2%
H
22.1
34.4
|
L
 68.1%
H
19.0
34.4
|
L
 -1.8%
H
14.6
34.6
|
L
 67.7%
H
9.3
35.8
|
L
 -36.1%
H
9.3
107.7
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
590.7
|
4.6
|
L
 1.8%
H
4.4
4.7
|
L
 18.5%
H
3.8
4.9
|
L
 21.9%
H
3.7
4.9
|
L
 12.4%
H
3.3
4.9
|
L
 -36.0%
H
2.4
7.3
|
L
 -68.6%
H
2.4
15.2
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
44.6
|
0.7
|
L
H
0.7
0.7
|
L
 -11.3%
H
0.7
0.8
|
L
 -24.5%
H
0.7
1
|
L
 -20.2%
H
0.7
1.2
|
L
 -21.1%
H
0.7
1.6
|
L
 -54.2%
H
0.7
4.6
|
L
 -91.6%
H
0.7
11.7
|
L
 -91.0%
H
0.7
15.0
|
| Citius Pharmaceuticals Inc |
|
23.1
|
1.3
|
L
 0.8%
H
1.2
1.3
|
L
 -20.9%
H
1.2
1.6
|
L
 -10.7%
H
1.2
2.2
|
L
 -3.1%
H
1.1
2.2
|
L
 -86.9%
H
0.1
12.8
|
L
 -95.1%
H
0.1
42.8
|
L
 -94.8%
H
0.1
114
|
L
 -99.7%
H
0.1
937.5
|
| CVRx Inc |
|
253.2
|
9.7
|
L
 -3.4%
H
9
10.3
|
L
 -4.7%
H
9
11.3
|
L
 11.2%
H
8.5
11.3
|
L
 39.9%
H
6.5
11.3
|
L
 -37.4%
H
4.3
18.6
|
L
 -22.7%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
305.1
|
8.6
|
L
H
8.3
8.7
|
L
 -12.1%
H
8.3
9.9
|
L
 -20%
H
8.3
12.7
|
L
 -15.2%
H
8.3
12.7
|
L
 -21.4%
H
8.3
18.2
|
L
 188%
H
2.3
18.2
|
L
 -25.2%
H
2.3
25.2
|
L
 -100.0%
H
2.3
1176000000
|
| Alpha Tau Medical |
|
328.3
|
3.9
|
L
 1.6%
H
3.8
3.9
|
L
 -7.2%
H
3.7
4.2
|
L
 -6.5%
H
3.7
4.5
|
L
 18.0%
H
3
4.7
|
L
 72.3%
H
2.1
4.7
|
L
 -9.6%
H
1.8
6.0
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
21,450.9
|
55
|
L
 -5.2%
H
54.1
58.3
|
L
 -5.5%
H
54.1
62.4
|
L
 -16.7%
H
54.1
72.1
|
L
 -28.0%
H
54.1
82.4
|
L
 -20.2%
H
54.1
93.2
|
L
 -52.3%
H
54.1
142
|
L
 -39.1%
H
54.1
164.9
|
L
 159.7%
H
10.7
164.9
|
| Daxor Corp |
|
64.6
|
13.0
|
L
 -1.3%
H
13.0
13.1
|
L
 -2.8%
H
12.8
13.5
|
L
 -3.6%
H
11.4
13.9
|
L
 23.4%
H
9.5
14
|
L
 40.6%
H
6.6
14
|
L
 2.0%
H
6.6
14
|
L
 -6.4%
H
6.6
17.6
|
L
 52.1%
H
3.4
24.1
|
| ElectroCore Inc |
|
46.6
|
5.8
|
L
 -0.2%
H
5.5
6.3
|
L
 15.7%
H
4.5
6.3
|
L
 17.8%
H
4.5
6.3
|
L
 18.7%
H
4.2
6.3
|
L
 -54.2%
H
4.2
19.5
|
L
 68.5%
H
2.9
19.5
|
L
 -75.2%
H
2.9
54.5
|
L
H
2.9
303.8
|
| Ekso Bionics Holdings Inc |
|
12.3
|
4.7
|
L
 -3.7%
H
4.5
4.9
|
L
 -13.4%
H
4.5
5.5
|
L
 -13.5%
H
4.5
5.6
|
L
 48.7%
H
2.9
5.7
|
L
 -97.7%
H
2.7
224.6
|
L
 -98.6%
H
2.7
704.0
|
L
 -99.5%
H
2.7
3370.5
|
L
 -100.0%
H
2.7
34020
|
| Embecta Corp |
|
806.5
|
13.8
|
L
 2.5%
H
13.5
13.9
|
L
 3.4%
H
13.0
13.9
|
L
 0.1%
H
13.0
14.6
|
L
 33.1%
H
11.6
15.6
|
L
 -9.8%
H
9.2
21.5
|
L
 -53.9%
H
9.2
36.6
|
L
H
9.2
63
|
L
H
9.2
63
|
| Establishment Labs Holdings |
|
1,883.1
|
65
|
L
 0.1%
H
62
65.5
|
L
 35.6%
H
47
65.5
|
L
 60.7%
H
38.4
65.5
|
L
 80.8%
H
33.4
65.5
|
L
 35.1%
H
26.6
65.5
|
L
 22.3%
H
17
79.9
|
L
 156.4%
H
17
93.8
|
L
H
7.6
93.8
|
| Exact Sciences Corp |
|
12,539.2
|
66.2
|
L
 -1.6%
H
64.9
67.3
|
L
 2.3%
H
64.0
72.8
|
L
 14.6%
H
57.8
72.8
|
L
 53.3%
H
40.6
72.8
|
L
 24.3%
H
38.8
72.8
|
L
 73.4%
H
38.0
100.8
|
L
 -46.6%
H
29.3
159.5
|
L
 585.1%
H
4.7
159.5
|
| Edap Tms SA Adr |
|
75.5
|
2.0
|
L
 1.5%
H
2.0
2.1
|
L
 -5.6%
H
1.9
2.2
|
L
 -8.2%
H
1.8
2.8
|
L
 56.6%
H
1.2
3.1
|
L
 -26.0%
H
1.2
3.1
|
L
 -80.4%
H
1.2
12.7
|
L
 -52.8%
H
1.2
12.7
|
L
 -63.2%
H
1.2
12.7
|
| GlucoTrack Inc |
|
5.1
|
5.6
|
L
 -3.0%
H
5.4
5.8
|
L
 -13.8%
H
5.4
6.5
|
L
 -25.1%
H
5.4
9.1
|
L
 -4.0%
H
4.2
14.1
|
L
 -99.6%
H
4.2
2147.5
|
L
 -99.9%
H
4.2
22500
|
L
 -100.0%
H
4.2
46800
|
L
 -100.0%
H
4.2
468000
|
| GE HealthCare Tech |
|
33,275.9
|
73.1
|
L
 -1.5%
H
72.7
74.1
|
L
 -2.5%
H
72.7
76.8
|
L
 -1.9%
H
70.0
79.8
|
L
 2.7%
H
69.8
79.8
|
L
 -17.3%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
24.0
|
0.5
|
L
 -1.8%
H
0.5
0.6
|
L
 3.9%
H
0.5
0.7
|
L
 22.7%
H
0.4
0.9
|
L
 5.9%
H
0.4
0.9
|
L
 -77.4%
H
0.3
2.6
|
L
 -78.5%
H
0.3
6.3
|
L
 -85.3%
H
0.3
8.8
|
L
 -82.9%
H
0.3
8.8
|
| Hologic |
|
16,492.2
|
74.1
|
L
 -0.1%
H
74.1
74.2
|
L
 0.3%
H
73.9
74.3
|
L
 9.4%
H
65
74.7
|
L
 9.1%
H
63.2
74.7
|
L
 -6.6%
H
51.9
80.2
|
L
 -0.3%
H
51.9
87.9
|
L
 -1.3%
H
51.9
87.9
|
L
 84.1%
H
26.5
87.9
|
| Heart Test Laboratories Inc |
|
8.0
|
2.6
|
L
 -4.4%
H
2.6
2.9
|
L
 -14.4%
H
2.6
3
|
L
 -30.0%
H
2.6
3.8
|
L
 -26.3%
H
2.6
3.9
|
L
 -6.8%
H
2.5
6.5
|
L
 -98.9%
H
2.4
395
|
L
H
2.4
600
|
L
H
2.4
600
|
| Helius Medical Technologies |
|
221.6
|
5.5
|
L
 3.2%
H
5.0
5.7
|
L
 -7.4%
H
4.5
6.0
|
L
 -69.7%
H
4.5
19.5
|
L
 -4.5%
H
4.5
25.5
|
L
 -98.7%
H
4.5
1200
|
L
 -99.9%
H
4.5
15732.2
|
L
 -100.0%
H
4.5
1275000
|
L
 -100.0%
H
4.5
27168750
|
| Henry Schein |
|
8,464.4
|
71.9
|
L
 2.6%
H
70.2
71.9
|
L
 13.8%
H
63.0
73.5
|
L
 10.8%
H
61.9
73.5
|
L
 9.1%
H
61.9
73.5
|
L
 3.6%
H
60.6
82.5
|
L
 -3.2%
H
60.0
89.7
|
L
 16.6%
H
60.0
92.7
|
L
 19.4%
H
41.9
92.7
|
| Hyperfine Inc Ordinary Shares |
|
101.1
|
1.1
|
L
 1.9%
H
1.0
1.1
|
L
 -4.5%
H
1.0
1.2
|
L
 -37.8%
H
1.0
2.2
|
L
 -7.0%
H
1.0
2.2
|
L
 10.3%
H
0.5
2.2
|
L
 33.8%
H
0.5
3.3
|
L
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings |
|
937.8
|
12.0
|
L
 7.3%
H
11.5
12.3
|
L
 0.3%
H
10.9
12.3
|
L
 -16.6%
H
10.9
16.5
|
L
 -4.7%
H
10.9
16.5
|
L
 -52.8%
H
10.9
27.1
|
L
 -75.5%
H
10.9
60.7
|
L
 -75.4%
H
10.9
77.4
|
L
 -62.6%
H
10.9
77.4
|
| Icecure Medical |
|
47.6
|
0.7
|
L
H
0.7
0.7
|
L
 -2.8%
H
0.7
0.8
|
L
 -31%
H
0.7
1.0
|
L
 -22.5%
H
0.7
1.4
|
L
 -6.8%
H
0.5
1.7
|
L
 -33.7%
H
0.5
4.7
|
L
 -56.9%
H
0.2
16
|
L
 -49.3%
H
0.2
16
|
| SeaStar Medical Holding Corp |
|
16.7
|
0.5
|
L
 6.5%
H
0.4
0.5
|
L
 -14.0%
H
0.4
0.6
|
L
 -23.4%
H
0.4
0.7
|
L
 -38.0%
H
0.4
1.3
|
L
 -80.4%
H
0.3
3.1
|
L
 -99.7%
H
0.2
173.5
|
L
H
0.2
550
|
L
H
0.2
550
|
| ICU Medical Inc |
|
3,460.1
|
140.2
|
L
 8.1%
H
136
149.5
|
L
 16.7%
H
116.6
149.5
|
L
 18.7%
H
112.5
149.5
|
L
 7.9%
H
107
149.5
|
L
 -21.5%
H
107
196.3
|
L
 -1.3%
H
78.4
212.4
|
L
 -25.5%
H
78.4
282
|
L
 17.8%
H
78.4
321.7
|
| IDEXX Laboratories |
|
56,570.7
|
708.5
|
L
 -0.7%
H
700.2
716.7
|
L
 12.5%
H
691.7
735
|
L
 12.9%
H
615
735
|
L
 9.0%
H
600.6
735
|
L
 63.6%
H
356.3
735
|
L
 83.9%
H
356.3
735
|
L
 48.2%
H
317.1
735
|
L
 904.3%
H
63.5
735
|
| Inspira Technologies Oxy BHN |
|
29.6
|
1.0
|
L
 -8.6%
H
1.0
1.0
|
L
 3.2%
H
0.9
1.1
|
L
 -16.5%
H
0.9
1.3
|
L
 -17.2%
H
0.9
1.5
|
L
 -29.4%
H
0.4
1.7
|
L
 -26.2%
H
0.4
2.5
|
L
H
0.4
9.6
|
L
H
0.4
9.6
|
| Intercure |
|
73.6
|
1.4
|
L
 -2.2%
H
1.3
1.4
|
L
 -3.6%
H
1.3
1.5
|
L
 -16.7%
H
1.3
1.7
|
L
 -9.4%
H
1.3
1.8
|
L
 -12.3%
H
1.2
1.8
|
L
 -72.4%
H
1.0
5.6
|
L
 -68.1%
H
1.0
12.7
|
L
H
1.0
19.4
|
| Inogen Inc |
|
189.8
|
7.0
|
L
 -0.6%
H
7.0
7.2
|
L
 -15.2%
H
7.0
8.3
|
L
 -18.6%
H
7.0
9.1
|
L
 19.1%
H
6.0
9.1
|
L
 -26.1%
H
5.7
12.9
|
L
 -66.5%
H
4.1
26.1
|
L
 -76.1%
H
4.1
82.4
|
L
 -85.2%
H
4.1
287.8
|
| Inmode |
|
913.4
|
14.5
|
L
 0.1%
H
14.3
14.6
|
L
 -2.2%
H
14.1
14.8
|
L
 -3.9%
H
14.1
16.7
|
L
 0.6%
H
13.8
16.7
|
L
 -25.9%
H
13.1
19.9
|
L
 -55.9%
H
13.1
48.3
|
L
 -30.2%
H
13.1
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
2.4
|
0.5
|
L
 8%
H
0.5
0.5
|
L
H
0.5
0.6
|
L
 -29.0%
H
0.5
2.1
|
L
 -70.2%
H
0.5
2.1
|
L
 -98.3%
H
0.5
37.4
|
L
 -99.9%
H
0.5
914.3
|
L
 -100.0%
H
0.5
8856
|
L
 -100.0%
H
0.5
25804.8
|
| IRIDEX Corp |
|
18.0
|
1.1
|
L
 1.9%
H
1.0
1.1
|
L
 1.0%
H
1.0
1.1
|
L
 -4.5%
H
1
1.2
|
L
 -15.9%
H
1
1.5
|
L
 -22.1%
H
0.8
2.0
|
L
 -49.8%
H
0.8
3.7
|
L
 -36.9%
H
0.8
9.7
|
L
 -87.5%
H
0.8
16.6
|
| Iradimed Corp |
|
1,072.8
|
84.3
|
L
 -0.3%
H
82.9
84.8
|
L
 9.8%
H
77.7
87.9
|
L
 13.4%
H
71.3
87.9
|
L
 22.3%
H
67.8
87.9
|
L
 51.1%
H
47.5
87.9
|
L
 192.3%
H
27.4
87.9
|
L
 285.8%
H
21.7
87.9
|
L
 164.4%
H
7.9
87.9
|
| iRhythm Technologies Inc |
|
5,625.5
|
174.6
|
L
 -1.6%
H
171.7
178.7
|
L
 -6.8%
H
171.7
189.3
|
L
 -1.7%
H
171.7
212
|
L
 8.5%
H
152.1
212
|
L
 96.7%
H
71
212
|
L
 73.8%
H
55.9
212
|
L
 -31.7%
H
41.7
286.2
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
198,517.8
|
560
|
L
 2.2%
H
541.7
562.7
|
L
 4.8%
H
527.6
562.7
|
L
 27%
H
427.8
562.7
|
L
 19.2%
H
427.8
562.7
|
L
 6.8%
H
425
616
|
L
 131.1%
H
222.7
616
|
L
 128.9%
H
180.1
616
|
L
 906.1%
H
55.0
616
|
| Jowell Global |
|
3.3
|
1.5
|
L
 -6.8%
H
1.5
1.6
|
L
 -9.6%
H
1.5
1.7
|
L
 -16.6%
H
1.5
2.5
|
L
 -18.8%
H
1.5
2.5
|
L
 -25.3%
H
1.5
3.7
|
L
 -92.5%
H
1
30.2
|
L
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific |
|
119.8
|
41.8
|
L
 3.4%
H
39.5
42
|
L
 -0.1%
H
39.5
43.0
|
L
 -4.8%
H
39.5
46.6
|
L
 -22.4%
H
39.5
60.9
|
L
 12.7%
H
30.3
71.3
|
L
 150.3%
H
14.6
71.3
|
L
 417.3%
H
8.2
71.3
|
L
 150.7%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
426.6
|
17.0
|
L
 3.7%
H
16.4
17.1
|
L
 1.0%
H
16
17.1
|
L
 -6.0%
H
15.3
18.9
|
L
 -11.4%
H
15.3
22.8
|
L
 -38.1%
H
15.3
28
|
L
 -58.5%
H
15.3
53.5
|
L
 -59.0%
H
15.3
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
180.3
|
3.9
|
L
 -1.5%
H
3.9
4.0
|
L
 -1.5%
H
3.8
4.1
|
L
 -0.8%
H
3.8
4.4
|
L
 0.8%
H
3.7
4.4
|
L
 38.3%
H
1.9
5.1
|
L
 76.5%
H
1.9
5.1
|
L
 -2.0%
H
1.8
6.5
|
L
 983.3%
H
0.3
12.8
|
| Standard BioTools Inc |
|
434.6
|
1.1
|
L
 0.9%
H
1.1
1.2
|
L
 -5.8%
H
1.1
1.2
|
L
 -13.1%
H
1.1
1.5
|
L
 -12.4%
H
1.1
1.5
|
L
 -48.2%
H
0.9
2.3
|
L
 11.9%
H
0.9
3.2
|
L
 -85.1%
H
0.9
7.5
|
L
 -89.0%
H
0.9
14.9
|
| LivaNova PLC |
|
2,754.8
|
50.5
|
L
 1.8%
H
49.7
52.0
|
L
 -4.1%
H
48.8
55.0
|
L
 -3.3%
H
48.8
55.3
|
L
 4.0%
H
48.6
58.9
|
L
 -2.9%
H
32.5
58.9
|
L
 1.2%
H
32.5
64.5
|
L
 3.7%
H
32.5
93.9
|
L
 -23.0%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,965.4
|
86.8
|
L
 1.4%
H
81.6
89.0
|
L
 0.2%
H
81.6
90
|
L
 0.0%
H
81.6
91.2
|
L
 -7.9%
H
81.6
101.0
|
L
 -14.1%
H
71.4
109.6
|
L
 95.8%
H
43.4
109.6
|
L
 143.3%
H
34.2
109.6
|
L
 526.9%
H
12.0
109.6
|
| LENSAR Inc |
|
126.6
|
10.6
|
L
 -7.3%
H
10.5
11.5
|
L
 -13.8%
H
10.5
12.7
|
L
 -12.1%
H
10.5
12.7
|
L
 -17.5%
H
10.5
13.1
|
L
 55.2%
H
6.5
17.3
|
L
 128.4%
H
1.8
17.3
|
L
 29.0%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
3,386.5
|
51.1
|
L
 -4.9%
H
50.7
54.3
|
L
 -11.5%
H
50.7
62
|
L
 -1.5%
H
49.7
62
|
L
 -6.9%
H
49.7
62
|
L
 -42.2%
H
47.3
111.3
|
L
 -9.3%
H
47.3
126.9
|
L
 353.1%
H
11.4
126.9
|
L
 1047.6%
H
1.8
126.9
|
| Lucid Diagnostics Inc |
|
141.1
|
1.1
|
L
 0.9%
H
1.1
1.1
|
L
 -10.7%
H
1.1
1.2
|
L
 2.9%
H
1.1
1.3
|
L
 10.2%
H
1.0
1.5
|
L
 8%
H
0.8
1.8
|
L
 -41.6%
H
0.6
2.4
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
78.2
|
1.9
|
L
 6.1%
H
1.8
1.9
|
L
 -4%
H
1.6
2.1
|
L
 11.0%
H
1.5
2.9
|
L
 18.5%
H
1.5
2.9
|
L
 -73.9%
H
1.5
9.4
|
L
 -61.5%
H
1.5
14.8
|
L
 -95.9%
H
1.5
69.5
|
L
H
1.5
69.5
|
| Masimo Corp |
|
7,689.7
|
143.2
|
L
 -0.5%
H
142.0
146.2
|
L
 1.8%
H
138.6
157.7
|
L
 -4.7%
H
138.6
157.7
|
L
 -1.2%
H
135.3
158.3
|
L
 -11.3%
H
133.7
194.9
|
L
 13.5%
H
75.2
198
|
L
 -43.8%
H
75.2
305.2
|
L
 232.0%
H
33.0
305.2
|
| 908 Devices Inc |
|
266.3
|
7.4
|
L
 -5.4%
H
7.3
7.9
|
L
 -7.5%
H
7.3
8.2
|
L
 -17.2%
H
7.3
9.3
|
L
 15.0%
H
5.3
9.3
|
L
 90.2%
H
1.8
9.3
|
L
 -48.3%
H
1.8
16.5
|
L
H
1.8
79.6
|
L
H
1.8
79.6
|
| Mimedx Group Inc |
|
1,101.9
|
7.4
|
L
 1.5%
H
7.2
7.5
|
L
 -2.8%
H
7.2
8.0
|
L
 2.5%
H
6.4
8.0
|
L
 4.6%
H
6.4
8.0
|
L
H
5.8
10.1
|
L
 143.1%
H
2.4
10.1
|
L
 19.8%
H
2.4
16.0
|
L
 -5.1%
H
1.0
18.3
|
| Meihua International Medical |
|
12.9
|
0.2
|
L
H
0.2
0.2
|
L
H
0.2
0.3
|
L
 -37.8%
H
0.2
0.4
|
L
 -42.5%
H
0.2
0.5
|
L
 -62.3%
H
0.2
0.8
|
L
 -97.2%
H
0.2
45.5
|
L
H
0.2
45.5
|
L
H
0.2
45.5
|
| Mesa Laboratories Inc |
|
419.8
|
76.0
|
L
 1.5%
H
70
80.0
|
L
 5.7%
H
70
80.0
|
L
 11.5%
H
66.6
80.8
|
L
 19.8%
H
58.8
80.8
|
L
 -35.5%
H
55.5
155.1
|
L
 -52.5%
H
55.5
206.4
|
L
 -71.4%
H
55.5
333.4
|
L
 -32.8%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
5,190.9
|
87.6
|
L
 1.2%
H
86.3
88.9
|
L
 0.0%
H
85.3
88.9
|
L
 5.9%
H
78.1
89.3
|
L
 2.2%
H
78.1
93.3
|
L
 -14.1%
H
78.1
111.5
|
L
 27.4%
H
62.6
111.5
|
L
 71.5%
H
49.6
111.5
|
L
 358.4%
H
15.5
111.5
|
| Modular Medical Inc |
|
28.7
|
0.5
|
L
 2.0%
H
0.5
0.5
|
L
 4%
H
0.5
0.6
|
L
 -22.4%
H
0.5
0.7
|
L
 -28.8%
H
0.5
1
|
L
 -76.6%
H
0.5
2.3
|
L
 -82.6%
H
0.5
3.8
|
L
 -95.4%
H
0.5
19.5
|
L
 -35.8%
H
0.5
19.5
|
| Myriad Genetics Inc |
|
587.2
|
6.3
|
L
 -0.5%
H
6.1
6.4
|
L
 -21.6%
H
6.1
8.4
|
L
 -16.3%
H
6.1
8.6
|
L
 3.3%
H
5.2
8.6
|
L
 -64.4%
H
3.8
19.6
|
L
 -61.3%
H
3.8
29.3
|
L
 -55.9%
H
3.8
37.0
|
L
 -85.7%
H
3.8
50.4
|
| MDxHealth SA ADR |
|
-
|
4.5
|
L
 -3.4%
H
4.3
4.7
|
L
 -8.7%
H
4.3
4.9
|
L
 -5.7%
H
3.9
5.3
|
L
 66.3%
H
2.6
5.3
|
L
 114.8%
H
1.4
5.3
|
L
 -38.2%
H
1.4
8.5
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
| NanoVibronix Inc |
|
4.1
|
4.7
|
L
 -3.1%
H
4.4
4.7
|
L
 -9.5%
H
4.4
5.3
|
L
 -24.0%
H
4.4
7.5
|
L
 -44.2%
H
0.7
17.4
|
L
 -93.8%
H
0.7
162.5
|
L
 -99.5%
H
0.7
1419.2
|
L
 -99.6%
H
0.7
9218
|
L
 -100.0%
H
0.7
18700
|
| ENDRA Life Sciences Inc |
|
7.8
|
5.2
|
L
 -11.5%
H
4.8
5.9
|
L
 -0.6%
H
4.8
6.0
|
L
 -17.0%
H
4.6
9.9
|
L
 22.5%
H
4
9.9
|
L
 -11.8%
H
2.9
12.0
|
L
 -97.4%
H
0.0
297.5
|
L
 -99.3%
H
0.0
3100
|
L
H
0.0
5880
|
| Neogen Corp |
|
1,390.7
|
6.4
|
L
 7.0%
H
6.0
6.5
|
L
 3.7%
H
5.9
6.5
|
L
 14.5%
H
5.6
7.2
|
L
 28%
H
4.9
7.2
|
L
 -59.4%
H
3.9
16.8
|
L
 -54.4%
H
3.9
24.1
|
L
 -82.0%
H
3.9
48.9
|
L
 -69.9%
H
3.9
48.9
|
| Nephros Inc |
|
48.8
|
4.6
|
L
 -11.5%
H
4.5
5.3
|
L
 -19.3%
H
4.5
5.8
|
L
 -19.0%
H
4.5
6.0
|
L
 59.2%
H
3.2
6.0
|
L
 196.8%
H
1.4
6.0
|
L
 322.0%
H
1.0
6.0
|
L
 -23.6%
H
0.9
11.7
|
L
 31.1%
H
0.9
11.7
|
| NeuroOne Medical Technologies |
|
34.5
|
0.7
|
L
 -4.2%
H
0.7
0.7
|
L
 -12.7%
H
0.7
0.8
|
L
 -34.9%
H
0.7
1.1
|
L
 -9.2%
H
0.7
1.2
|
L
 -23.3%
H
0.4
1.4
|
L
 -31%
H
0.4
2.9
|
L
 -76.8%
H
0.4
13.5
|
L
H
0.4
30
|
| Nano X Imaging |
|
195.0
|
3.1
|
L
 -3.2%
H
2.9
3.1
|
L
 -16.0%
H
2.9
3.7
|
L
 -23.4%
H
2.9
4.5
|
L
 -34.0%
H
2.9
4.9
|
L
 -49.3%
H
2.9
11
|
L
 -77.4%
H
2.9
22.7
|
L
 -91.0%
H
2.9
94.8
|
L
H
2.9
94.8
|
| NeuroPace Inc |
|
437.0
|
13.1
|
L
 2.7%
H
12.5
13.4
|
L
 32.0%
H
9.2
13.8
|
L
 23.2%
H
9.2
13.8
|
L
 47.1%
H
7.6
13.8
|
L
 73.5%
H
6.6
19.0
|
L
 463.1%
H
1.2
19.0
|
L
H
1.2
27.4
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
133.0
|
1.8
|
L
 -7.7%
H
1.8
2.0
|
L
 -18.1%
H
1.8
2.4
|
L
 -25.2%
H
1.8
2.5
|
L
 -24.3%
H
1.8
2.6
|
L
 -24.0%
H
1.8
3.8
|
L
 67.6%
H
0.8
3.9
|
L
 -65.5%
H
0.8
22.2
|
L
 -100.0%
H
0.8
701465.6
|
| Nortech Systems Inc |
|
27.0
|
9.7
|
L
H
9.7
9.7
|
L
 4.0%
H
9.4
9.7
|
L
 8.2%
H
9.1
10.0
|
L
 19.1%
H
8.0
10.0
|
L
 -5.5%
H
7.3
12.4
|
L
 -17.0%
H
7.3
19.2
|
L
 108.2%
H
4.2
19.6
|
L
 125.6%
H
1.7
19.6
|
| Natera Inc |
|
27,447.5
|
199.6
|
L
 0.6%
H
182.2
201.2
|
L
 0.3%
H
182.2
203.2
|
L
 18.4%
H
168.0
203.2
|
L
 41.5%
H
149.4
203.2
|
L
 53.1%
H
125.4
203.2
|
L
 367.5%
H
34
203.2
|
L
 143.1%
H
26.1
203.2
|
L
 2112.5%
H
6.5
203.2
|
| Nutriband Inc |
|
72.5
|
6.0
|
L
 9.0%
H
5.6
6.1
|
L
 -10.4%
H
5.5
6.7
|
L
 -23.1%
H
5.5
8.6
|
L
 -15.4%
H
5.5
8.6
|
L
 8.5%
H
3.7
11.8
|
L
 36.4%
H
1.5
11.8
|
L
 -38.8%
H
0.9
27.4
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
2.6
|
2.9
|
L
 3.2%
H
2.8
2.9
|
L
 0.4%
H
2.6
3.0
|
L
 -26.8%
H
2.6
4
|
L
 -45.5%
H
2.6
6.7
|
L
 -96.1%
H
2.6
107.9
|
L
 -100.0%
H
2.6
35681
|
L
 -100.0%
H
2.6
1819771.8
|
L
 -100.0%
H
2.6
10000000000
|
| NovoCure |
|
1,222.8
|
10.9
|
L
 -3.1%
H
10.7
11.1
|
L
 -14.8%
H
10.7
12.8
|
L
 -22.9%
H
10.7
14.7
|
L
 -5.1%
H
10.7
14.8
|
L
 -38.1%
H
10.7
34.1
|
L
 -84.9%
H
10.7
120.0
|
L
 -91.3%
H
10.7
232.8
|
L
 -57.5%
H
6.0
232.8
|
| enVVeno Medical Corporation |
|
13.1
|
0.7
|
L
 -1.5%
H
0.6
0.7
|
L
 -7.1%
H
0.6
0.7
|
L
 -32.3%
H
0.6
1
|
L
 -86.3%
H
0.6
5.1
|
L
 -81.5%
H
0.6
5.6
|
L
 -89.1%
H
0.6
7.0
|
L
 -92.1%
H
0.6
17.7
|
L
H
0.6
141
|
| Nexalin Technology Inc |
|
23.8
|
1.3
|
L
 4.8%
H
1.2
1.3
|
L
 -12.7%
H
1.2
1.5
|
L
 39.4%
H
1.2
2
|
L
 40.9%
H
0.7
2
|
L
 -61.5%
H
0.7
4.5
|
L
 -20.1%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
184.7
|
4.9
|
L
 -2.0%
H
4.8
5.1
|
L
 -5.2%
H
4.8
5.3
|
L
 -24.5%
H
4.8
6.9
|
L
 -34.4%
H
4.3
8.6
|
L
 -49.0%
H
4.3
11.9
|
L
 -16.6%
H
4
20
|
L
H
4
37
|
L
H
4
37
|
| Nanobiotix ADR |
|
958.0
|
19.9
|
L
 1.0%
H
19.0
20.1
|
L
 -4.8%
H
17.4
20.7
|
L
 -5.3%
H
14.8
30.4
|
L
 176.4%
H
7.0
30.4
|
L
 357.8%
H
2.8
30.4
|
L
 435.6%
H
1.8
30.4
|
L
H
1.8
30.4
|
L
H
1.8
30.4
|
| Orchestra BioMed Holdings Inc |
|
215.1
|
3.8
|
L
H
3.5
3.9
|
L
 -2.3%
H
3.5
4.0
|
L
 39.6%
H
2.7
4.1
|
L
 46.5%
H
2.2
4.1
|
L
 -36.6%
H
2.2
6.5
|
L
 -61.9%
H
2.2
23.4
|
L
 -65.0%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
592.4
|
15.0
|
L
 1.9%
H
14.6
15.2
|
L
 -3.1%
H
14.5
17.0
|
L
 5.4%
H
13.9
17.0
|
L
 17.8%
H
12.4
17.0
|
L
 -17.9%
H
10.2
20.7
|
L
 -4.7%
H
9.6
23.2
|
L
 -57.5%
H
9.6
48.5
|
L
 -63.8%
H
9.6
74.4
|
| Outset Medical Inc |
|
214.3
|
12.1
|
L
 2.1%
H
11.4
12.3
|
L
 -8.1%
H
11.4
13.3
|
L
 -19.7%
H
11.4
16.2
|
L
 -15.0%
H
11.4
16.2
|
L
 3.6%
H
0.5
25.4
|
L
 -93.5%
H
0.5
458.3
|
L
 -98.3%
H
0.5
1004.4
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc |
|
714.5
|
5.6
|
L
 44.7%
H
5.0
6.2
|
L
 32.5%
H
3.8
6.2
|
L
 36.0%
H
3.8
6.2
|
L
 24.6%
H
3.6
6.2
|
L
 72.7%
H
2.6
6.7
|
L
 71.6%
H
1.8
6.7
|
L
 40.4%
H
1.8
24.3
|
L
H
1.8
310.9
|
| Orasure Technologies Inc |
|
172.2
|
2.4
|
L
H
2.4
2.4
|
L
 -12.4%
H
2.3
2.8
|
L
 -24.1%
H
2.3
3.3
|
L
 -12.4%
H
2.3
3.5
|
L
 -43.4%
H
2.3
4.4
|
L
 -45.2%
H
2.3
8.5
|
L
 -82.0%
H
2.3
15.9
|
L
 -59.5%
H
2.3
23.0
|
| Pacific Biosciences of |
|
531.4
|
1.8
|
L
 -1.1%
H
1.6
1.8
|
L
 -24.8%
H
1.6
2.3
|
L
 25.7%
H
1.4
2.4
|
L
 39.7%
H
1.2
2.4
|
L
 -28.2%
H
0.9
2.7
|
L
 -79.1%
H
0.9
14.6
|
L
 -87.8%
H
0.9
53.7
|
L
 -76.1%
H
0.9
53.7
|
| PAVmed Inc |
|
8.9
|
0.3
|
L
H
0.3
0.3
|
L
 -25.6%
H
0.3
0.4
|
L
 -34.7%
H
0.3
0.6
|
L
 -22.0%
H
0.3
0.6
|
L
 -69.8%
H
0.3
1.3
|
L
 -69.5%
H
0.2
4.4
|
L
 -81.6%
H
0.2
9.7
|
L
H
0.2
15.2
|
| ProDex Inc co |
|
101.0
|
31.0
|
L
 -5.0%
H
31.0
32.5
|
L
 -14.6%
H
31.0
36.9
|
L
 -5.7%
H
23.5
36.9
|
L
 -33.5%
H
23.5
48.8
|
L
 -24.7%
H
23.5
70.3
|
L
 80.5%
H
14.5
70.3
|
L
 -9.9%
H
12.4
70.3
|
L
 1013.3%
H
2.2
70.3
|
| Pulse Biosciences Inc |
|
1,047.7
|
15.5
|
L
 -1.7%
H
15.2
15.9
|
L
 -8.7%
H
15.0
17.0
|
L
 -22.2%
H
15.0
20.2
|
L
 5.0%
H
13.8
20.4
|
L
 -14.0%
H
13.8
25
|
L
 639.7%
H
1.7
25
|
L
 27.2%
H
1.2
45.8
|
L
H
1.2
45.8
|
| Predictive Oncology Inc |
|
21.9
|
6.3
|
L
 -0.6%
H
4.8
6.4
|
L
 -29.8%
H
4.8
9.5
|
L
 -56.1%
H
4.8
15.1
|
L
 -44.6%
H
4.8
32.1
|
L
 -49.6%
H
4.8
45.9
|
L
 -92.0%
H
4.8
208.2
|
L
 -96.8%
H
4.8
690
|
L
 -100.0%
H
4.8
507000
|
| Precision Optics Corp Inc |
|
31.9
|
4.1
|
L
 -0.7%
H
4.1
4.1
|
L
 -3.7%
H
4.1
4.3
|
L
 -1.4%
H
3.8
4.4
|
L
 -13.4%
H
3.8
5.1
|
L
 -8.2%
H
3.8
5.5
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
22,498.3
|
319.8
|
L
 -1.1%
H
316.9
333.0
|
L
 2.2%
H
290.2
335
|
L
 2.0%
H
290.2
335.3
|
L
 5.4%
H
288.0
353.5
|
L
 30.6%
H
230.1
353.5
|
L
 5.4%
H
125.8
353.5
|
L
 24.4%
H
125.8
353.5
|
L
 786.2%
H
23.9
353.5
|
| Procept BioRobotics Corp |
|
1,783.6
|
31.9
|
L
 2.0%
H
29.8
32.0
|
L
 -6.2%
H
29.8
35.7
|
L
 -7.8%
H
29.8
37.3
|
L
 -19.4%
H
29.8
42.7
|
L
 -66.8%
H
29.8
103.8
|
L
 -18.7%
H
24.8
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ordinary |
|
207.7
|
12.3
|
L
H
11.7
12.9
|
L
 -16.7%
H
11.7
14.8
|
L
 -14.2%
H
11.7
18.0
|
L
 54.4%
H
7.2
18.0
|
L
 178.6%
H
3.1
18.0
|
L
 -72.6%
H
2.9
47.7
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
179.7
|
6.0
|
L
 2.2%
H
5.7
6.0
|
L
 -1.5%
H
5.6
6.2
|
L
 -7.4%
H
5.2
7.2
|
L
 5.5%
H
3.8
7.2
|
L
 -33.3%
H
3.8
9.2
|
L
 19.1%
H
3.8
15.5
|
L
 -66.6%
H
3.1
29.0
|
L
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
1,382.4
|
20.4
|
L
 -4.3%
H
20.1
21.6
|
L
 -24.6%
H
20.1
28.0
|
L
 -26.5%
H
20.1
30.9
|
L
 -16.6%
H
20.1
32.8
|
L
 -47.6%
H
20.1
49.5
|
L
 -77.0%
H
20.1
102
|
L
 -92.8%
H
20.1
265
|
L
 -6.7%
H
13.2
306.7
|
| Quanterix Corp |
|
229.5
|
4.9
|
L
 -1%
H
4.8
5
|
L
 -7.5%
H
4.8
5.5
|
L
 -12.7%
H
4.8
6.3
|
L
 -10.3%
H
4.2
6.3
|
L
 -67.3%
H
4.1
15.7
|
L
 -48.8%
H
4.1
29.7
|
L
 -90.1%
H
4.1
92.6
|
L
H
4.1
92.6
|
| AVITA Medical Inc |
|
115.0
|
3.8
|
L
 10.9%
H
3.4
3.8
|
L
 -2.6%
H
3.4
3.9
|
L
 -31.1%
H
3.4
5.6
|
L
 -29.9%
H
3.4
7.1
|
L
 -69.6%
H
3.4
14.2
|
L
 -24.6%
H
3.4
21.7
|
L
 -82.5%
H
3.4
28.5
|
L
 -51.0%
H
3.4
55.4
|
| Rockwell Medical Inc |
|
34.1
|
1.0
|
L
 -2.0%
H
1.0
1.0
|
L
 -10.8%
H
1.0
1.1
|
L
 -16.8%
H
1.0
1.3
|
L
 1.0%
H
0.9
2.1
|
L
 -76.4%
H
0.8
5.2
|
L
 13.8%
H
0.8
6.2
|
L
 -89.8%
H
0.8
21.8
|
L
 -99.2%
H
0.8
136.6
|
| Vyome Holdings Inc |
|
30.3
|
5.5
|
L
 -2.7%
H
5.0
5.6
|
L
 -8.9%
H
5.0
6.6
|
L
 -11.3%
H
4.7
6.6
|
L
 104.1%
H
1.9
12.9
|
L
 2.4%
H
0.3
12.9
|
L
 -99.3%
H
0.3
1299.2
|
L
 -99.9%
H
0.3
93699
|
L
H
0.3
1381560
|
| Rewalk Robotics |
|
32.5
|
0.5
|
L
 1.9%
H
0.5
0.5
|
L
 -12.9%
H
0.5
0.6
|
L
 -32.5%
H
0.5
0.8
|
L
 -20.6%
H
0.5
0.9
|
L
 -58.5%
H
0.5
1.3
|
L
 -92.0%
H
0.5
9.1
|
L
 -93.3%
H
0.5
42
|
L
 -100.0%
H
0.5
3045
|
| Sanmina Corp |
|
9,270.9
|
170.3
|
L
 -1.3%
H
165
174
|
L
 24.3%
H
136.5
178.4
|
L
 35.6%
H
121.9
178.4
|
L
 43.1%
H
108.4
178.4
|
L
 104.2%
H
63.7
178.4
|
L
 188.8%
H
43.4
178.4
|
L
 537.9%
H
27.5
178.4
|
L
 589.8%
H
16.3
178.4
|
| Sight Sciences Inc |
|
304.8
|
5.8
|
L
 16.4%
H
5.4
5.9
|
L
 15.0%
H
4.9
5.9
|
L
 67.7%
H
3.2
5.9
|
L
 63.9%
H
3.2
5.9
|
L
 24.4%
H
2.0
5.9
|
L
 -26.5%
H
1.0
15.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
4,454.6
|
15.7
|
L
 -2.1%
H
15.3
15.8
|
L
 -5.5%
H
15.3
17.8
|
L
 -2.5%
H
15.3
17.8
|
L
 39.8%
H
12.9
17.8
|
L
H
9.5
17.8
|
L
 146.2%
H
5.8
19.4
|
L
H
5.8
30.4
|
L
H
5.8
30.4
|
| SIBONE Inc |
|
680.3
|
15.8
|
L
 3.8%
H
14.9
15.9
|
L
 6.3%
H
14.5
15.9
|
L
 2.9%
H
14.5
16
|
L
 -3.4%
H
13.8
16.9
|
L
 1.3%
H
11.7
20.1
|
L
 -6.0%
H
11.1
29.5
|
L
 -25.2%
H
11.1
37.2
|
L
H
7.2
37.2
|
| SINTX Technologies Inc |
|
9.0
|
3.3
|
L
 -3.5%
H
3.2
3.4
|
L
 2.5%
H
3.0
3.5
|
L
 -22.3%
H
3.0
4.6
|
L
 22.0%
H
2.7
6.8
|
L
 12.8%
H
1.7
8.6
|
L
 -99.8%
H
0.1
3020
|
L
 -100.0%
H
0.1
68800
|
L
 -100.0%
H
0.1
29192400
|
| Beauty Health Company The |
|
177.6
|
1.4
|
L
 8.5%
H
1.3
1.7
|
L
 -2.1%
H
1.3
1.7
|
L
 -15.2%
H
1.3
1.8
|
L
 -12.0%
H
1.3
2.7
|
L
 -16.7%
H
0.8
2.7
|
L
 -87.6%
H
0.8
13.9
|
L
H
0.8
30.2
|
L
H
0.8
30.2
|
| Semler Scientific Inc |
|
417.9
|
27.6
|
L
 0.7%
H
25.5
27.8
|
L
 4.3%
H
23.6
30.5
|
L
 -2.7%
H
21.8
33.4
|
L
 -26.5%
H
21.8
38.2
|
L
 -27.2%
H
21.8
81.6
|
L
 -4.2%
H
19.1
81.6
|
L
 -58.2%
H
19.1
153.2
|
L
 716.6%
H
1.1
153.2
|
| Sanara MedTech Inc |
|
246.8
|
27.7
|
L
 -0.5%
H
26.5
28
|
L
 -5.4%
H
26.3
29.2
|
L
 -8.6%
H
26.3
35
|
L
 13.8%
H
24.4
36.0
|
L
 -18.3%
H
23.5
39.1
|
L
 -14.6%
H
23.5
50.2
|
L
 -16%
H
17.4
53.9
|
L
 347.1%
H
2
75
|
| Surmodics Inc |
|
383.0
|
26.8
|
L
 1.4%
H
26.1
27.3
|
L
 -2.4%
H
25.9
28.7
|
L
 -7.0%
H
25.9
29
|
L
 -23.5%
H
25.9
38.6
|
L
 -30.2%
H
25.9
40.4
|
L
 -25.0%
H
16
42.4
|
L
 -23.8%
H
16
62.3
|
L
 19.3%
H
16
82.4
|
| Sensus Healthcare Inc |
|
69.0
|
4.2
|
L
 19.3%
H
3.5
4.3
|
L
 31.7%
H
3.1
4.3
|
L
 18.3%
H
3.1
4.3
|
L
 -21.5%
H
3.0
4.3
|
L
 -35.8%
H
3.0
9.3
|
L
 -42.7%
H
1.8
9.6
|
L
 77.2%
H
1.8
15.3
|
L
H
1.8
15.3
|
| STRATA Skin Sciences Inc |
|
9.3
|
1.6
|
L
 1.2%
H
1.5
1.7
|
L
 -7.9%
H
1.5
1.8
|
L
 -15.0%
H
1.5
2.7
|
L
 -14.1%
H
1.4
3.9
|
L
 -47.1%
H
1.4
3.9
|
L
 -81.6%
H
1.4
41
|
L
 -87.3%
H
1.4
41
|
L
 -97.0%
H
1.4
76.5
|
| Staar Surgical Co |
|
1,310.7
|
26.6
|
L
 -0.3%
H
24.6
26.8
|
L
 2.6%
H
24.6
26.8
|
L
 -0.6%
H
23.9
28.0
|
L
 -1.5%
H
23.9
30.8
|
L
 -15.6%
H
13.5
31.4
|
L
 -55.0%
H
13.5
81.8
|
L
 -66.7%
H
13.5
163.1
|
L
 211.6%
H
5.0
163.1
|
| Neuronetics Inc |
|
156.1
|
2.3
|
L
 -9.5%
H
2.2
2.5
|
L
 -14.0%
H
2.2
3.1
|
L
 -21.7%
H
2.2
3.2
|
L
 -43%
H
2.2
4.3
|
L
 111.1%
H
0.5
5.9
|
L
 -38.4%
H
0.5
7.0
|
L
 -66.7%
H
0.5
22.4
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
32.4
|
10.0
|
L
 -2.1%
H
9.3
10.9
|
L
 -8.4%
H
9.3
11.2
|
L
 -14.2%
H
9.3
11.6
|
L
 399.5%
H
2.0
12.0
|
L
 185.2%
H
1.7
12.0
|
L
 89.4%
H
1.7
12.0
|
L
 -32.8%
H
1.7
27
|
L
 -96.9%
H
1.7
346
|
| Sharps Technology Inc |
|
109.0
|
3.9
|
L
 1.9%
H
3.7
3.9
|
L
 -12.5%
H
3.7
4.4
|
L
 -38.7%
H
3.7
6.9
|
L
 -22.8%
H
3.7
18.2
|
L
 -99.6%
H
0.0
1248.3
|
L
 -99.9%
H
0.0
13464
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Technology Inc |
|
555.3
|
24.9
|
L
 4.2%
H
23.0
25.1
|
L
 65.0%
H
15.3
25.1
|
L
 67.5%
H
14
25.1
|
L
 99.8%
H
12.0
25.1
|
L
 62.9%
H
8.6
25.1
|
L
 257.2%
H
7.7
26.1
|
L
 -30.2%
H
6.3
64.5
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
46.4
|
1.2
|
L
 -0.9%
H
1.1
1.2
|
L
 -4.9%
H
1.1
1.4
|
L
 -25.5%
H
1.1
1.6
|
L
 -29.5%
H
1.1
2.1
|
L
 -60.9%
H
0.9
3.3
|
L
 -84.9%
H
0.9
13.2
|
L
 -92.8%
H
0.9
18
|
L
H
0.9
23.5
|
| Tivic Health Systems Inc |
|
3.8
|
2.2
|
L
 -0.5%
H
2.1
2.3
|
L
 -11.2%
H
2.1
2.7
|
L
 -23.9%
H
2.1
3.2
|
L
 -29.0%
H
2.1
5.6
|
L
 -49.7%
H
2.1
15.6
|
L
 -99.9%
H
2.1
3009.7
|
L
H
2.1
11050
|
L
H
2.1
11050
|
| Treace Medical Concepts Inc |
|
281.8
|
4.5
|
L
 -28.4%
H
3.4
4.5
|
L
 -30.2%
H
3.4
6.7
|
L
 -25.7%
H
3.4
7.1
|
L
 -21.5%
H
3.4
7.8
|
L
 -43.5%
H
3.4
10.8
|
L
 -78.8%
H
3.4
28.0
|
L
H
3.4
37.2
|
L
H
3.4
37.2
|
| Transmedics Group Inc |
|
4,072.6
|
119.2
|
L
 -4.7%
H
115.2
123.0
|
L
 -9.4%
H
115.2
131.6
|
L
 3.5%
H
107.2
140.9
|
L
 2.7%
H
101
140.9
|
L
 39.4%
H
55
145.5
|
L
 105.9%
H
36.4
177.4
|
L
 830.3%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,102.5
|
16.3
|
L
 22.0%
H
15.2
16.7
|
L
 16.1%
H
13.2
16.7
|
L
 12.0%
H
13.2
16.7
|
L
 41.2%
H
10
16.7
|
L
 -51.2%
H
10.0
38.3
|
L
 -57.6%
H
10.0
53.7
|
L
 -86.1%
H
10.0
155.9
|
L
 -84.7%
H
2.1
155.9
|
| Trinity Biotech Plc ADR |
|
17.5
|
0.9
|
L
 -2.1%
H
0.9
1.0
|
L
 -6%
H
0.9
1.0
|
L
 -11.3%
H
0.9
1.2
|
L
 -95.8%
H
0.9
86
|
L
 -97.8%
H
0.9
86
|
L
 -99.9%
H
0.9
881.3
|
L
 -100.0%
H
0.9
4262.5
|
L
 -100.0%
H
0.9
8550
|
| Utah Medical Products Inc |
|
183.9
|
57.4
|
L
 -0.8%
H
57.3
57.9
|
L
 -1.2%
H
55.7
59.5
|
L
 -9.2%
H
55.7
63.5
|
L
 3.1%
H
55.3
64.5
|
L
 -14.6%
H
51.3
69.0
|
L
 -35.7%
H
51.3
109.5
|
L
 -29.4%
H
51.3
133.9
|
L
 -1.6%
H
51.3
133.9
|
| Vivani Medical Inc |
|
110.9
|
1.5
|
L
 3.4%
H
1.4
1.5
|
L
 -5.6%
H
1.4
1.7
|
L
 11.0%
H
1.3
1.9
|
L
 11.8%
H
1.1
1.9
|
L
 20.6%
H
0.9
1.9
|
L
 -14.1%
H
0.8
7.8
|
L
 -33.0%
H
0.8
60
|
L
 -99.0%
H
0.8
184.8
|
| Veracyte Inc |
|
3,296.4
|
41.7
|
L
 0.0%
H
40.0
41.9
|
L
 15.6%
H
35.3
46.4
|
L
 20.5%
H
33.2
46.4
|
L
 50.7%
H
26.6
46.4
|
L
 11.7%
H
22.6
47.3
|
L
 68.6%
H
18.6
47.3
|
L
 -2.9%
H
14.9
86.0
|
L
 489.0%
H
4.2
86.0
|
| Venus Concept Inc |
|
3.6
|
1.9
|
L
 -3.5%
H
1.9
2
|
L
 -9.8%
H
1.9
2.2
|
L
 -18.6%
H
1.9
2.8
|
L
 -20.9%
H
1.9
2.8
|
L
 370.7%
H
0.3
14.5
|
L
 -41.2%
H
0.3
14.5
|
L
 -94.0%
H
0.3
51.6
|
L
H
0.3
2688.8
|
| Varex Imaging Corp |
|
497.0
|
12.0
|
L
 0.7%
H
11.7
12.1
|
L
 2.4%
H
11.5
12.2
|
L
 3.6%
H
10.8
12.7
|
L
 53.3%
H
8.4
12.7
|
L
 -16.1%
H
6.8
16.9
|
L
 -44.8%
H
6.8
23.9
|
L
 -15.3%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
19.3
|
2.6
|
L
 10.8%
H
2.3
2.6
|
L
 -0.4%
H
2.3
2.6
|
L
 -17.1%
H
2.3
3.3
|
L
 -43.1%
H
2.3
4.9
|
L
 -5.5%
H
2.0
8.0
|
L
 -84.4%
H
1.9
74.1
|
L
H
1.9
360.3
|
L
H
1.9
360.3
|
| Wrap Technologies Inc |
|
106.1
|
2.1
|
L
 -8.0%
H
2.0
2.2
|
L
 -26.7%
H
2.0
2.9
|
L
 -27.5%
H
2.0
2.9
|
L
 67.5%
H
1.2
3
|
L
 34.6%
H
1.2
3
|
L
 53.7%
H
1.0
7.0
|
L
 -67.5%
H
1.0
9.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
14.0
|
1.8
|
L
 1.7%
H
1.6
1.8
|
L
 -14.6%
H
1.6
2.1
|
L
 -27.9%
H
1.6
2.8
|
L
 -38.0%
H
1.6
4.8
|
L
 -82.7%
H
1.6
13.5
|
L
 -98.7%
H
1.6
154.8
|
L
 -98.4%
H
1.6
328.2
|
L
H
1.6
900
|
| DENTSPLY Sirona Inc |
|
2,231.0
|
11.2
|
L
 1.5%
H
10.7
11.3
|
L
 -11.3%
H
10.7
12.7
|
L
 -9.3%
H
10.7
13.3
|
L
 -15.5%
H
10.7
14.9
|
L
 -35.2%
H
10.7
20.6
|
L
 -60.1%
H
10.7
43.2
|
L
 -75.6%
H
10.7
69.5
|
L
 -81.9%
H
10.7
69.5
|
| XTL Biopharmaceuticals |
|
8.8
|
1
|
L
H
1.0
1.1
|
L
 -6.5%
H
1.0
1.1
|
L
 -28.6%
H
1.0
2.6
|
L
 -29.6%
H
1.0
2.6
|
L
 -46.2%
H
0.9
2.6
|
L
 -23.1%
H
0.8
5.0
|
L
 -56.1%
H
0.8
6.7
|
L
 -89.1%
H
0.6
8.8
|
| 111 Inc ADR |
|
36.2
|
4.2
|
L
 -2.6%
H
3.9
4.3
|
L
 -4.4%
H
3.9
4.4
|
L
 -11.3%
H
3.9
4.9
|
L
 -38.7%
H
3.9
7.5
|
L
 472.6%
H
0.4
11.3
|
L
 46.7%
H
0.4
11.3
|
L
 -38.9%
H
0.4
45.9
|
L
H
0.4
45.9
|
| Jin Medical International |
|
42.3
|
0.3
|
L
 3.9%
H
0.2
0.3
|
L
 17.4%
H
0.2
0.4
|
L
 -46%
H
0.2
0.6
|
L
 -57.8%
H
0.2
0.9
|
L
 -86.2%
H
0.2
2.0
|
L
H
0.2
509.9
|
L
H
0.2
509.9
|
L
H
0.2
509.9
|
| Zynex Inc |
|
31.5
|
1.0
|
L
 -1.0%
H
1.0
1.1
|
L
 -9.6%
H
1.0
1.2
|
L
 -28.3%
H
1.0
1.5
|
L
 -29.3%
H
1.0
1.7
|
L
 -88.2%
H
1.0
9.3
|
L
 -92.1%
H
1.0
17.3
|
L
 -91.3%
H
1.0
20.8
|
L
 593.3%
H
0.1
27.0
|
| HeartBeam Inc |
|
56.6
|
1.7
|
L
 1.9%
H
1.5
1.7
|
L
 -10.8%
H
1.5
1.9
|
L
 -6.3%
H
1.5
1.9
|
L
 75.5%
H
0.9
2.0
|
L
 -34%
H
0.9
3.5
|
L
 4.4%
H
0.9
3.5
|
L
 4.4%
H
0.9
3.5
|
L
 4.4%
H
0.9
3.5
|
| Cencora |
|
69,931.8
|
360.7
|
L
 0.1%
H
358.3
364.4
|
L
 6.8%
H
335.2
364.4
|
L
 16.8%
H
305.6
364.4
|
L
 29.6%
H
278.2
364.4
|
L
 45.6%
H
223.9
364.4
|
L
 122.6%
H
147.1
364.4
|
L
 247.0%
H
94.9
364.4
|
L
 269.5%
H
68.4
364.4
|
| Incannex Healthcare ADR |
|
121.7
|
0.4
|
L
 -2.8%
H
0.3
0.4
|
L
 -7.9%
H
0.3
0.4
|
L
 -20.5%
H
0.3
0.5
|
L
 -23.9%
H
0.3
0.8
|
L
 -85.5%
H
0.1
3.1
|
L
 -93.6%
H
0.1
5.3
|
L
 -93.6%
H
0.1
5.3
|
L
 -93.6%
H
0.1
5.3
|
| Rewalk Robotics |
|
8.5
|
0.5
|
L
 1.9%
H
0.5
0.5
|
L
 -12.9%
H
0.5
0.6
|
L
 -32.5%
H
0.5
0.8
|
L
 -20.6%
H
0.5
0.9
|
L
 -74.4%
H
0.5
4
|
L
 -92.0%
H
0.5
9.1
|
L
 -93.3%
H
0.5
42
|
L
 -100.0%
H
0.5
3045
|
| Work Medical Technology Group |
|
3.8
|
3.7
|
L
 0.8%
H
3.4
3.9
|
L
 2.0%
H
3.2
3.9
|
L
 -51.2%
H
2.8
10.5
|
L
 -95.4%
H
2.8
93
|
L
 -99.4%
H
2.8
844.6
|
L
H
2.8
844.6
|
L
H
2.8
844.6
|
L
H
2.8
844.6
|
| Pheton Holdings Ordinary |
|
8.6
|
0.6
|
L
H
0.6
0.6
|
L
 -3.2%
H
0.5
0.7
|
L
 -18.9%
H
0.5
0.7
|
L
 -32.6%
H
0.5
1.2
|
L
 -86.9%
H
0.5
32
|
L
H
0.5
32
|
L
H
0.5
32
|
L
H
0.5
32
|
| Ceribell Inc |
|
444.4
|
12.0
|
L
 3.6%
H
11.3
12.0
|
L
 5.1%
H
10.9
12.0
|
L
 1.5%
H
10.9
13.9
|
L
 -4.8%
H
10.9
13.9
|
L
 -58.6%
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Technologies Global |
|
143.5
|
4.0
|
L
 -1.2%
H
3.7
4.0
|
L
 -11.4%
H
3.7
4.7
|
L
 -8.9%
H
3.7
6.5
|
L
 10.3%
H
3.2
6.5
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
| Beta Bionics Inc |
|
1,157.8
|
26.3
|
L
 5.0%
H
24.9
26.5
|
L
 -3.4%
H
24.3
28.4
|
L
 18.7%
H
19.5
30.5
|
L
 74.3%
H
14.0
30.5
|
L
H
8.9
30.5
|
L
H
8.9
30.5
|
L
H
8.9
30.5
|
L
H
8.9
30.5
|
| Wellgistics Health Inc |
|
65.4
|
0.6
|
L
 -7.3%
H
0.6
0.7
|
L
 -8.6%
H
0.6
0.7
|
L
 -11.1%
H
0.3
1.5
|
L
 -15.8%
H
0.3
1.9
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
| Kestra Medical Technologies |
|
1,349.0
|
26.2
|
L
 0.5%
H
24.9
27
|
L
 -4.2%
H
24.4
27.4
|
L
 7.5%
H
21.9
30
|
L
 77.8%
H
14.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
266.3
|
31.1
|
L
 17.7%
H
28.0
31.7
|
L
 7.4%
H
25.8
31.7
|
L
 -2.9%
H
25.8
36.4
|
L
 -9.4%
H
25.8
46.6
|
L
 -3.8%
H
24.8
46.6
|
L
 -3.8%
H
24.8
46.6
|
L
 -3.8%
H
24.8
46.6
|
L
 -3.8%
H
24.8
46.6
|
| SS Innovations International |
|
1,318.6
|
6.8
|
L
 -5.4%
H
6.2
7.3
|
L
 -16.5%
H
6.2
8.2
|
L
 0.4%
H
6.2
10
|
L
 2.0%
H
5.2
10
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|